By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works Collective
  • Health
    • Mental Health
    Health
    Healthcare organizations are operating on slimmer profit margins than ever. One report in August showed that they are even lower than the beginning of the…
    Show More
    Top News
    headphones can create health problems
    The Harmful Health Effects of Using Headphones
    September 24, 2021
    Headache causes
    4 Causes Of Headache You Probably Didn’t Know About
    December 28, 2021
    follow these steps to recover from your injury
    What Steps Should You Take to Recover More Quickly from an Injury?
    April 12, 2022
    Latest News
    Clean Your Mattress Properly to Avoid Common Health Issues
    March 29, 2023
    5 Benefits Of HIPAA-Compliant Answering Services
    March 28, 2023
    3 Ways To Deal With Health Issues In Cities With High Pollution
    March 22, 2023
    What Tools Should Your Caregiver Have?
    March 22, 2023
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
    Policy and Law
    Get the latest updates about Insurance policies and Laws in the Healthcare industry for different geographical locations.
    Show More
    Top News
    Health Literacy Resources
    October 30, 2012
    Getting Young Invincibles to Buy Health Insurance?
    March 16, 2014
    doctor patient relationship
    The Importance of Human Touch in Clinical Medicine
    February 3, 2013
    Latest News
    What Are Bioidentical Hormones Made With?
    March 23, 2023
    Cover Medical Costs of Child Dog Bites with Legal Specialists
    March 23, 2023
    3 Ways to Improve the U.S. Healthcare System By 2030
    March 14, 2023
    6 Steps To Ensure Speed And Efficiency Of Clinical Studies
    March 14, 2023
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: FDA’s Dr. Katz Talks Social Media and Clinical Trials
Share
Sign In
Notification Show More
Latest News
improve self-esteem to fight depression
7 Ways to Enhance Your Self-Esteem to Fight Depression
Mental Health
healthy travel tips when visiting Australia
7 Essential Tips to Stay Safe and Healthy Visiting Australia
News
health risks of dirty mattress
Clean Your Mattress Properly to Avoid Common Health Issues
Health
eligble for NDIS?
Are You Eligible For NDIS? How To Apply
News
upgrade to your nursing career
4 Pertinent Ways to Upgrade Your Nursing Career
Nursing
Aa
Health Works CollectiveHealth Works Collective
Aa
Search
Have an existing account? Sign In
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Policy & Law > Public Health > FDA’s Dr. Katz Talks Social Media and Clinical Trials
BusinesseHealthPublic HealthSocial MediaTechnology

FDA’s Dr. Katz Talks Social Media and Clinical Trials

Eileen O'Brien
Last updated: 2013/03/27 at 8:13 AM
Eileen O'Brien
Share
8 Min Read
social media healthcare
SHARE

social media healthcareI was fortunate to be invited to speak at the American Society for Experimental NeuroTherapeutics (ASENT) annual meeting on February 28, 2013 in Bethedsa, MD.

social media healthcareI was fortunate to be invited to speak at the American Society for Experimental NeuroTherapeutics (ASENT) annual meeting on February 28, 2013 in Bethedsa, MD. What’s unique about this nonprofit organization is that it consists of representatives from the key stakeholder areas: healthcare, academia, biopharma, patient advocacy and government. At their event I met physicians, nurses, patients, advocacy leaders, brand managers and FDA officials.

I presented as part of an afternoon discussion on the “Use of the Internet and Social Media to Conduct Clinical Trials” with Russell Katz, MD, U.S. Food and Drug Administration (FDA); Joseph Kim, Shire Pharmaceuticals; Craig Lipset, Pfizer; Joanna Napp, HealthTronics; Lori Sames, Hannah’s Hope Fund; and Nancy Santilli, HealthTronics.

Dr. Katz, director of the Division of Neurology Products in the FDA’s Center for Drug Evaluation and Research, started off by admitting that not only was he not an expert in social media, but he doesn’t even have a smart phone! He’d asked around to see if anyone at the FDA was investigating the use of social media specifically for clinical trials and did not find anyone. Dr. Katz noted that the overarching idea is that the existing advertising rules apply, but it’s not yet clear how. He said, “The agency is working on it.” He mentioned that the FDA is working on an app to accept MedWatch reports via phone.

More Read

AI in healthcare education

Colleges Prove the Huge Benefits of AI in Healthcare Education

The Evolution of Mental Health Technology Helps Treat OCD
Best Practices for Healthcare Call Centers Should Follow in 2023
How Hospitals and Other Healthcare Providers Can Boost Employee Morale
8 Advances in Medical Technology That Are Changing Everything

Dr. Katz said that using social media for real time adverse event reporting, patients supporting each other and helping with trial adherence were all positives. Dr. Katz didn’t feel that designing a clinical trial via crowd sourcing would be a regulatory issue and mentioned the example of Transparency Life Sciences multiple sclerosis trial. He explained that using social media for recruitment was fine, but that the real issue relates to large numbers of patients interacting during a trial. On this same topic, Craig showed a blog on Fingolimod (where patients were sharing specific detailed info on how to get into a trial) which generated a lively discussion. Another conversation was around the ability for patients to “blind break” a trial via their social media use. Participants have always done this, but with social media it can happen on a much larger scale.

Many of the other sessions were also fascinating and I’ve provided a summary of a few.

What motivates patients to participate in trials?
Petra Kaufmann, MD, from the National Institute of Neurological Disorders and Stroke talked about the challenge of clinical trial patient recruitment and retention. The Neuropathy Association did a survey and learned that people would be motivated to participate by access to leading doctors (35%), access to new treatments (35%) and helping others (25%). Survey respondents identified the barriers as lack of awareness, ability to travel and hidden costs, such as missing work. Dr. Kaufmann shared quotes from patients who were frustrated because specifically asking doctors about trials didn’t work for them. She recommended including patient feedback to ensure the burden is acceptable, planning for reimbursing hidden costs and sharing information back with patients. Dr. Kaufmann advised increasing awareness of clinical trials by including patients in the trial design to ensure that the questions being asked and the outcomes matter to patients, and that information flows back. She recommended having patients help develop the clinical trial communication plan to ensure patient-friendly language and that the information will be shared in the appropriate places.

Dr. Amy Chappell from Eli Lilly explained how they put these ideas into practice and how their process includes patients and advocacy groups at the beginning of trials. She illustrated how patients and doctors don’t always agree, so it’s important to ask both groups.

Communicate, communicate, communicate!
Bray Patrick-Lane, MFS, PFO Research Foundation, gave a powerful personal example of how communication between industry and clinical trial patients is not always ideal. She has migraines and was in a clinical trial with a device implanted and only learned about the discontinuation of the trial via a news report.

Patrick-Lane noted that organizations create tools for the public domain which is what biopharma should also do. Patients get frustrated when things aren’t shared in public domain. She highlighted the new focus on rewarding results not just the process. Examples include Prize4Life and Clinical Trials Transformation Initiative.

Robin Elliott, MA, Parkinson’s Disease Foundation, talked about the small print of the medication prescribing information and that the lengthy information is intimidating to patients who might not be able to accurately assess the risks. Elliott described how patient activists will help spread information to non-activist patients. He explained that caregivers and family members play an important role in medication choice.

How do doctors decide what to prescribe?
James Simsarian, MD, a key opinion leader on multiple sclerosis (MS), discussed the process for making medical decisions. He explained that for non-life threatening diseases the patient’s family and online research have big impact. According to Dr. Simsarian, a treatment decision often comes down to a one on one conversation between the doctor and the patient. His patients often ask the question, would I be better doing nothing?

Dr. Simsarian quoted a study that showed that MS patients with a higher level of disability were more willing to take risks. Personally, he likes drugs after they’ve been on the market for 18 months. He noted that doctor bias is determined by how this drug worked on the last few patients. An audience member raised that the “hassle factor” also plays a role in what to prescribe. For example, how much time will I have to take to explain this medication? How many calls on side effects will I get?

The FDA and patients
Dr. Katz also presented “Integrating Patient Input Within the Drug Approval Process.” The Food and Drug Administration Safety and Innovation Act (FDASIA) made provisions for increased patient participation in medical product regulation.

Dr. Katz said that at the recent amyotrophic lateral sclerosis (ALS) meeting, the FDA heard from many patients. Recurrent themes were that patients were willing to take significant risks and they felt that the inclusion criteria were too rigid. Dr. Katz said that patient reported outcomes are critical and reiterated the importance of the FDA hearing directly from patients. He noted that the ALS meeting “had a significant effect on FDA staff—we don’t yet know what the outcome will be, but the agency took this very seriously.” Dr. Katz ended with, “We are in a new period of getting patients more involved on the entire process.”

TAGGED: clinical trials

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.
By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
Eileen O'Brien March 27, 2013
Share this Article
Facebook Twitter Copy Link Print
Share
Previous Article Image Exchanges Offer More Than Just a Product under ACA
Next Article MBAs for Practicing Physicians: Learning to Lead in the New Millennium

Stay Connected

1.5k Followers Like
4.5k Followers Follow
2.8k Followers Pin
136k Subscribers Subscribe

Latest News

improve self-esteem to fight depression
7 Ways to Enhance Your Self-Esteem to Fight Depression
Mental Health March 31, 2023
healthy travel tips when visiting Australia
7 Essential Tips to Stay Safe and Healthy Visiting Australia
News March 29, 2023
health risks of dirty mattress
Clean Your Mattress Properly to Avoid Common Health Issues
Health March 29, 2023
eligble for NDIS?
Are You Eligible For NDIS? How To Apply
News March 29, 2023

You Might also Like

hipaa-compliant answering services
Policy & Law

5 Benefits Of HIPAA-Compliant Answering Services

March 28, 2023
blockchain in healthcare for the NHS
Technology

How Blockchain Can Help the National Health Service

March 27, 2023
virtual reality in optometry
Technology

Virtual Reality Visual Field Test Device in Healthcare

March 22, 2023
valueable healthcare programs
News

5 Most Valuable Healthcare Programs in 2023

March 8, 2023
//

We influence million of users and is the most authentic source of information on healthcare business and technology news.

Quick Links

  • About
  • Contact
  • Privacy
Subscribe

Subscribe to our newsletter to get our newest articles instantly!

Follow US

© 2008-2023 HealthWorks Collective. All Rights Reserved.

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?